Canature Health Technology Co., Ltd. (SHE:300272)
China · Delayed Price · Currency is CNY 5.12
-0.20 (-3.76%)
Jul 24, 2026, 3:04 PM CST
SHE:300272 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 40.52 | 56.01 | 70.39 | 132.45 | 92.56 | 104.86 |
Depreciation & Amortization | 89.61 | 89.61 | 84.06 | 76.91 | 75.76 | 52.12 |
Other Amortization | 9.36 | 9.36 | 4.49 | 2.31 | 4.57 | 11.6 |
Loss (Gain) From Sale of Assets | 0.14 | 0.14 | 0.11 | -2.42 | -1.55 | 0.18 |
Asset Writedown & Restructuring Costs | 0.09 | 0.09 | 0.08 | 0.09 | 15.47 | 6.52 |
Loss (Gain) From Sale of Investments | 43.71 | 43.71 | 22.46 | -5.13 | -3.74 | -35.38 |
Provision & Write-off of Bad Debts | 2.88 | 2.88 | 1.26 | 2.36 | 0.55 | 2.78 |
Other Operating Activities | 47.67 | 94.94 | 61.48 | 45.58 | 18.2 | 30.84 |
Change in Accounts Receivable | -3.74 | -3.74 | -8.07 | -4.74 | 26.17 | -137.99 |
Change in Inventory | -45.69 | -45.69 | -13.1 | 62.38 | -37.84 | -65 |
Change in Accounts Payable | 53.93 | 53.93 | 58.66 | 62.6 | -39.9 | 218.53 |
Change in Other Net Operating Assets | - | - | 18.63 | 1.64 | 0.3 | 0.47 |
Operating Cash Flow | 236.84 | 299.61 | 292.05 | 374.83 | 155.44 | 186.77 |
Operating Cash Flow Growth | -28.42% | 2.59% | -22.09% | 141.15% | -16.78% | 33.00% |
Capital Expenditures | -129.34 | -144.72 | -130.86 | -80.24 | -94.58 | -71.29 |
Sale of Property, Plant & Equipment | 17.72 | 16.95 | 0.14 | 0.57 | 2.64 | 4.7 |
Cash Acquisitions | - | - | - | - | 0 | 7.06 |
Divestitures | - | - | - | -8.43 | - | 99.88 |
Investment in Securities | 47.84 | 117.35 | -178.76 | -262.11 | 27.12 | -41.03 |
Other Investing Activities | 5.22 | 5.65 | 0.15 | - | 5.01 | 0.16 |
Investing Cash Flow | -58.3 | -4.5 | -309.07 | -349.67 | -59.81 | -0.51 |
Long-Term Debt Issued | - | 1,356 | 1,162 | 1,124 | 518.85 | 409.78 |
Total Debt Issued | 1,439 | 1,356 | 1,162 | 1,124 | 518.85 | 409.78 |
Long-Term Debt Repaid | - | -981.14 | -1,211 | -643.52 | -357.88 | -427.33 |
Total Debt Repaid | -991.42 | -981.14 | -1,211 | -643.52 | -357.88 | -427.33 |
Net Debt Issued (Repaid) | 447.43 | 375.19 | -49.08 | 480.69 | 160.97 | -17.55 |
Issuance of Common Stock | - | - | - | 44.69 | - | 2.29 |
Repurchase of Common Stock | -9.68 | - | -29.06 | - | -31.37 | -38 |
Common Dividends Paid | -135.64 | -132.57 | -182.2 | -78.16 | -69.87 | -40.86 |
Other Financing Activities | -289.62 | -65.71 | -11.67 | -16.94 | -28.75 | -2.49 |
Financing Cash Flow | 12.49 | 176.91 | -272.01 | 430.29 | 30.98 | -96.6 |
Foreign Exchange Rate Adjustments | -27.35 | -14.84 | 12.34 | 20.45 | 14.82 | 0.84 |
Net Cash Flow | 163.69 | 457.18 | -276.68 | 475.9 | 141.43 | 90.49 |
Free Cash Flow | 107.5 | 154.89 | 161.19 | 294.59 | 60.85 | 115.48 |
Free Cash Flow Growth | -40.83% | -3.91% | -45.28% | 384.12% | -47.30% | 18.70% |
Free Cash Flow Margin | 5.82% | 8.41% | 9.35% | 17.62% | 3.66% | 7.64% |
Free Cash Flow Per Share | 0.18 | 0.27 | 0.28 | 0.51 | 0.11 | 0.20 |
Cash Income Tax Paid | 56 | 60.47 | 61.97 | 45.22 | 18.42 | 19.91 |
Levered Free Cash Flow | 50.34 | 124.09 | 160.65 | 165.73 | 107.38 | 107.21 |
Unlevered Free Cash Flow | 79.19 | 152.13 | 186.8 | 183.5 | 117.91 | 117.39 |
Change in Working Capital | 2.87 | 2.87 | 47.72 | 122.68 | -46.38 | 13.25 |